Meet BIOTYPE at ESGO 2023!

We are pleased to introduce our participation at the 23rd European Congress on Gynaecological Oncology, taking place from September 28-October 1, 2023, Istanbul, Türkiye.

Genetic analysis of solid tumors is crucial for effective cancer diagnosis, staging, and treatment. Our solutions enable precise molecular tumor analysis on standard real-time PCR systems. For a comprehensive approach, explore our MODAPLEX platform, which streamlines multi-marker and multi-gene analysis within 4 hours including data analysis and report compilation.

Join us at booth B2-21 and discover our newly available MODAPLEX platform and MODAPLEX assay portfolio for molecular analysis of actionable biomarkers! Our Endometrium Cancer panel includes assays for testing POLE/POLD1, MSI and Copy Number High, following the ESGO recommended molecular-based TCGA classification for endometrial cancer.

Interested in learning more about MODAPLEX?

Meet with our delegates at Booth B2-21! They will be happy to answer all your questions and to discuss how BIOTYPE can help facilitate the optimal application for your diagnostic needs.